We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Asterand’s Subsidiary BioSeek Extends Collaboration with Merck Serono

News   Mar 29, 2012

 
Asterand’s Subsidiary BioSeek Extends Collaboration with Merck Serono
 
 
 

RELATED ARTICLES

Lung Therapy Targets Derived From Fetal Signaling Pathways

News

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought.

READ MORE

Therapy Combo Promising in Small Cell Lung Cancer Model

News

A combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.

READ MORE

Drug Combo Could Become New Standard Treatment for Advanced Kidney Cancer

News

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a Phase 3 clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE